EXICURE, INC. Class of Warrant or Right, Outstanding
EXICURE, INC. (XCUR) had Class of Warrant or Right, Outstanding of 0 shares as of 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2024-06-06
- 2023-12-31: Class of Warrant or Right, Outstanding 0.00 shares.
- 2023-09-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2023-06-30: Class of Warrant or Right, Outstanding 0.00 shares.
- 2023-03-31: Class of Warrant or Right, Outstanding 526.00K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-12-31 | 0.00 shares 10-K · filed 2024-06-06 |
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-05-16 |
| 2023-06-30 | 0.00 shares 10-Q/A · filed 2024-06-06 |
| 2023-03-31 | 526.00K shares 10-Q/A · filed 2024-06-06 |
| 2022-12-31 | 0.00 shares 10-Q/A · filed 2024-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |